Year archive

GenFleet Therapeutics (Shanghai) Inc. — 2026 filings

All 31 regulatory filings released by GenFleet Therapeutics (Shanghai) Inc. (2595) in 2026, sourced directly from the official regulator.

31 Filings

2026 Period

2026 filings (31)

Filing	Released	Lang
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 11, 2026 Declaration of Voting Results & Voting Rights Announcements	2026-05-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026 Regulatory Filings	2026-05-07	English
VOLUNTARY ANNOUNCEMENT Statement on the Proprietary Intellectual Property Status of GFH276, a Pan RAS (ON) Inhibitor Regulatory Filings	2026-04-28	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, 11 MAY 2026 Proxy Solicitation & Information Statement	2026-04-17	English
NOTICE OF THE 2025 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2026-04-17	English
CIRCULAR OF THE 2025 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2026-04-17	English
2025 Annual Report Annual Report FY 2025	2026-04-17	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026 Regulatory Filings	2026-04-09	English
VOLUNTARY ANNOUNCEMENT GFH375 Granted with Second Breakthrough Therapy Designation, as The First KRAS G12D Inhibitor Monotherapy Included in China's Breakthrough Therapy Designation List for Pancreati Regulatory Filings	2026-04-09	English
Terms of Reference of the Nomination Committee of the Board of Directors Governance Information	2026-03-25	English
Terms of Reference of the Remuneration Committee of the Board of Directors Governance Information	2026-03-25	English
Terms of Reference of the Audit Committee of the Board of Directors Governance Information	2026-03-25	English
(1) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025; (2) CHANGE OF THE JOINT COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT; AND (3) WAIVER FROM STRICT COMPLIANCE WITH Earnings Release FY 2025	2026-03-25	English
VOLUNTARY ANNOUNCEMENT Preclinical Research Data of Three Large- and Small-molecule Targeted Therapies Relevant to RAS Pathway to Be Presented at 2026 AACR Annual Meeting Regulatory Filings	2026-03-20	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-11	English
VOLUNTARY ANNOUNCEMENT INCLUSION INTO THE STOCK LIST OF THE STOCK CONNECT PROGRAM (SHANGHAI-HONG KONG STOCK CONNECT AND SHENZHEN-HONG KONG STOCK CONNECT) Regulatory Filings	2026-03-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2026 Regulatory Filings	2026-03-05	English
VOLUNTARY ANNOUNCEMENT GFH375 Granted with First Breakthrough Therapy Designation in China for a KRAS G12D Inhibitor Treating Non-small Cell Lung Cancer Regulatory Filings	2026-03-02	English
VOLUNTARY ANNOUNCEMENT INCLUSION AS A CONSTITUENT OF HANG SENG INDEX SERIES AND MSCI INDEX Regulatory Filings	2026-02-13	English
ARTICLES OF ASSOCIATION Share Issue/Capital Change	2026-02-09	English
(1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FEBRUARY 9, 2026; AND (2) ABOLISHMENT OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION Declaration of Voting Results & Voting Rights Announcements	2026-02-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2026 Share Issue/Capital Change	2026-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-02	English
Documents on Display Regulatory Filings	2026-01-23	English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, FEBRUARY 9, 2026 Proxy Solicitation & Information Statement	2026-01-23	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2026-01-23	English
(1) PROPOSED ADOPTION OF THE H SHARE OPTION SCHEME (2) PROPOSED ADOPTION OF THE H SHARE INCENTIVE SCHEME (3) PROPOSED AUTHORISATION TO THE BOARD OF DIRECTORS AND/OR AUTHORIZED PERSON(S) TO HANDLE Proxy Solicitation & Information Statement	2026-01-23	English
PROPOSED ABOLISHMENT OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION Declaration of Voting Results & Voting Rights Announcements	2026-01-20	English
Poll Results of the Annual General Meeting Held on 20 January 2026 Declaration of Voting Results & Voting Rights Announcements	2026-01-20	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2025 Regulatory Filings	2026-01-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-01-02	English

Filings by year

2026 31 filings
2025 59 filings
2024 30 filings
2023 29 filings
2022 34 filings
2021 33 filings
2020 27 filings
2019 24 filings
2018 52 filings
2017 39 filings
2016 25 filings
2015 23 filings
2014 29 filings
2013 38 filings
2012 33 filings
2011 18 filings
2010 34 filings
2009 23 filings
2008 15 filings
2007 10 filings
2006 17 filings
2005 10 filings
2004 18 filings
2003 9 filings
2002 9 filings